Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation | Zendy

Danielle M. Zerr | Zendy; Lawrence Corey | Zendy; Hyung W. Kim | Zendy; MeeiLi Huang | Zendy; Long Nguy | Zendy; Michael Boeckh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation

Author(s) -

Danielle M. Zerr,

Lawrence Corey,

Hyung W. Kim,

MeeiLi Huang,

Long Nguy,

Michael Boeckh

Publication year - 2005

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/428060

Subject(s) - medicine , hematopoietic stem cell transplantation , human herpesvirus 6 , stem cell , transplantation , haematopoiesis , hematopoietic cell , human herpesvirus , immunology , virology , hematopoietic stem cell , herpesviridae , viral disease , human immunodeficiency virus (hiv) , biology , genetics

Although human herpesvirus 6 (HHV-6) is known to reactivate during hematopoietic stem cell transplantation (HSCT), the clinical significance of this finding is controversial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research